Uterine Cancer On the Rise Highlighting Drastic Disparities Among Black and Hispanic/LatinX Women

hands holding a stethoscope

Cancer experts are ringing alarm bells due to the rise in uterine cancer.

Uterine cancer is on the rise highlighting drastic disparities among women of color.

Cancer experts are ringing alarm bells due to the rise in uterine cancer.

Black women with uterine cancer die at twice the rate of white women according to a new study published in JAMA Oncology. This represents one of the largest gaps in cancer disparities. It was also found that Black women are more likely to have to have a more aggressive non-endometrioid type that is correlated with obesity.

Black and Hispanic women  were "less likely than white women to undergo hysterectomy, less likely to have their lymph nodes properly biopsied to see if the cancer had spread and less likely to receive chemotherapy, even for a more threatening cancer."

This report also provides personal experiences of women who were brushed off when they pursued treatment for abnormal uterine bleeding, especially if they did not have insurance. 

One story highlighted the fact that many women have not been educated about the most important symptom of uterine cancer, vaginal bleeding after menopause. This leads to deadly delays in diagnosis. 

This new research, and the stories shared here, should raise concern among clinicians and researchers.

-

This content has been reviewed by the Laura W. Bush Institute for Women’s Health Scientific Council and is not meant to serve as medical advice or replace the opinion of your healthcare provider.

Related Stories

Research

ASCO GU Symposium Announces New Findings on Tumor Reduction and Survival Outcomes in Advanced Renal Cell Carcinoma

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at TTUHSC and director of the UMC Cancer Center, shared groundbreaking findings from the landmark CLEAR study.

Research

Researcher Develops Method to Measure Blood-Brain Barrier Permeability Accurately

Quentin R. Smith, Ph.D., from the Department of Pharmaceutical Sciences at the TTUHSC Jerry H. Hodge School of Pharmacy, sought to reconcile discrepancies in the field and provide accurate methods for measuring permeability over a very broad range.

Research

TTUHSC Researchers Developing Lupus Treatment

Jon McCord, Ph.D., a recent postdoc at the TTUHSC School of Medicine, and Bryan Sutton, Ph.D., from TTUHSC’s Department of Cell Physiology and Molecular Biophysics, study a mutation in a specific protein found in lupus patients. Together, they aim to become the force behind this new, patent pending therapy.

Recent Stories

Research

ASCO GU Symposium Announces New Findings on Tumor Reduction and Survival Outcomes in Advanced Renal Cell Carcinoma

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at TTUHSC and director of the UMC Cancer Center, shared groundbreaking findings from the landmark CLEAR study.

Education

Guest Named Abilene Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Heather Guest, Ph.D., R.N., has been named the Texas Tech University Health Sciences Center (TTUHSC) School of Nursing regional dean in Abilene. TTUHSC School of Nursing Dean Holly Wei, Ph.D., R.N., made the announcement, effective Jan. 1, 2025.

Research

Researcher Develops Method to Measure Blood-Brain Barrier Permeability Accurately

Quentin R. Smith, Ph.D., from the Department of Pharmaceutical Sciences at the TTUHSC Jerry H. Hodge School of Pharmacy, sought to reconcile discrepancies in the field and provide accurate methods for measuring permeability over a very broad range.